Price T Rowe Associates Inc Sesen Bio, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $81,512 - $190,910	-214,506 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $31,551 - $46,784	-54,400 Reduced 20.23%	214,506 $129,000
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $155,455 - $272,579	212,953 Added 380.59%	268,906 $219,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $150,740 - $322,225	-69,147 Reduced 55.27%	55,953 $259,000
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $162,630 - $405,324	125,100 New	125,100 $325,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.